Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart M Sprague

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 2, 2008
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney diseaseDennis L Andress, Daniel W Coyne, Kamyar Kalantar-Zadeh, et al.
American Journal of Nephrology|January 23, 2019
Cortical Perfusion and Tubular Function as Evaluated by Magnetic Resonance Imaging Correlates with Annual Loss in Renal Function in Moderate Chronic Kidney DiseasePottumarthi V Prasad, Lu-Ping Li, Jon M Thacker, et al.
American Journal of Nephrology|August 27, 2024
Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism PatientsCharles W Bishop, Akhtar Ashfaq, Stephen A Strugnell, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 31, 2018
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patientsMarkus Ketteler, Stuart M Sprague, Adrian C Covic, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2015
Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary HyperparathyroidismStuart M Sprague, James B Wetmore, Konstantin Gurevich, et al.
Plos One|October 3, 2015
Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional StudyPottumarthi V Prasad, Jon Thacker, Lu-Ping Li, et al.
Kidney Medicine|August 1, 2020
Sucroferric Oxyhydroxide in Maintenance Hemodialysis: A Retrospective, Comparative Cohort StudyDaniel W Coyne, Linda H Ficociello, Vidhya Parameswaran, et al.
American Journal of Nephrology|June 4, 2025
Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical TrialCharles W Bishop, Akhtar Ashfaq, John Choe, et al.
Journal of Biomedical Materials Research. Part A|October 16, 2010
Early tissue response to citric acid-based micro- and nanocompositesEun Ji Chung, Hongjin Qiu, Pradeep Kodali, et al.
American Journal of Nephrology|January 28, 2021
Medullary Blood Oxygen Level-Dependent MRI Index (R2*) is Associated with Annual Loss of Kidney Function in Moderate CKDLu-Ping Li, Jon M Thacker, Wei Li, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 2, 2008
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney diseaseDennis L Andress, Daniel W Coyne, Kamyar Kalantar-Zadeh, et al.
American Journal of Nephrology|January 23, 2019
Cortical Perfusion and Tubular Function as Evaluated by Magnetic Resonance Imaging Correlates with Annual Loss in Renal Function in Moderate Chronic Kidney DiseasePottumarthi V Prasad, Lu-Ping Li, Jon M Thacker, et al.
American Journal of Nephrology|August 27, 2024
Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism PatientsCharles W Bishop, Akhtar Ashfaq, Stephen A Strugnell, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 31, 2018
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patientsMarkus Ketteler, Stuart M Sprague, Adrian C Covic, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2015
Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary HyperparathyroidismStuart M Sprague, James B Wetmore, Konstantin Gurevich, et al.
Plos One|October 3, 2015
Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional StudyPottumarthi V Prasad, Jon Thacker, Lu-Ping Li, et al.
Kidney Medicine|August 1, 2020
Sucroferric Oxyhydroxide in Maintenance Hemodialysis: A Retrospective, Comparative Cohort StudyDaniel W Coyne, Linda H Ficociello, Vidhya Parameswaran, et al.
American Journal of Nephrology|June 4, 2025
Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical TrialCharles W Bishop, Akhtar Ashfaq, John Choe, et al.
Journal of Biomedical Materials Research. Part A|October 16, 2010
Early tissue response to citric acid-based micro- and nanocompositesEun Ji Chung, Hongjin Qiu, Pradeep Kodali, et al.
American Journal of Nephrology|January 28, 2021
Medullary Blood Oxygen Level-Dependent MRI Index (R2*) is Associated with Annual Loss of Kidney Function in Moderate CKDLu-Ping Li, Jon M Thacker, Wei Li, et al.
Pageof 12